Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Drug Development Consulting BidCo ApS
APS
Active
Advertising protection
CVR 42287067
Smedeland 36, 2600
Glostrup
Business and other management consultancy activities
·
NACE 7020
Est. 2021 · 5 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Business and other management consultancy activities
/
Drug Development Consulting BidCo ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
1M
2M
3M
5M
-4M
2021
4M
2022
2M
2023
3M
2024
EBITDA
DKK millions
3M
0M
-2M
-4M
-6M
-5M
2021
2M
+140%
2022
-1M
-150%
2023
1M
+200%
2024
Income statement
DKK thousands
Item
2021
2022
2023
2024
Gross profit
-4.389
3.760
2.320
3.438
Staff expenses
-931
-1.938
-2.942
-2.724
EBITDA
-5.320
1.822
-622
714
Depreciation & amort.
-0
-0
-0
-0
EBIT
-5.320
1.822
-622
714
Net financials
-10.783
-14.390
-9.708
-14.630
Profit before tax
-15.401
-12.568
-10.330
-13.916
Tax
351
-737
-949
-701
Net profit
-15.752
-11.831
-9.381
-13.215
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
Total assets
129.982
124.307
120.669
126.045
Equity
70.809
71.831
70.212
78.983
Long-term debt
53.630
48.310
45.590
0
Short-term debt
5.543
4.166
4.867
47.062
Total debt
59.173
52.476
50.457
47.062
Financial ratios
5-year trend
EBITDA margin (of gross profit)
20.8%
This company
2021
2024
Equity ratio
62.7%
This company
38.2%
Market median
+64% vs market
2021
2024
Return on equity
-16.7%
This company
18.4%
Market median
-191% vs market
2021
2024
Net profit margin (of gross profit)
-384.4%
This company
2021
2024
Asset turnover (of gross profit)
0.03×
This company
2021
2024
Debt / equity
0.60×
This company
0.62×
Market median
+3% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-04-08 – 2021-12-31
View
PDF
More on Drug Development Consulting BidCo ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
